March 3, 2026Exploratory Research in Clinical and Social Pharmacy0 citationsOpen Access

Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center

AUAbdullah UmerAga Khan University AMAdam Khan MohmandAga Khan University NKNaimal Mouzam KhanAga Khan University

Key Points

Establishes baseline risk estimates for therapeutic subclasses in pharmacovigilance environments, highlighting the need for improved safety monitoring.
Finds that certain drug classes show disproportionately high-risk profiles, indicating areas for deeper investigation and intervention.
Assessment indicates the robustness of the Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) as tools for drug safety evaluation.
Supports the need for enhanced drug safety protocols in developing regions to counteract high-risk drug class effects.

Abstract

This analysis establishes baseline class-level risk estimates in a developing pharmacovigilance environment, identifies disproportionately high-risk drug classes, and supports the robustness of PRR and ROR as complementary screening tools for regional drug safety monitoring.

KI fragen

Bookmark

View Full Paper

Cite This Study

Umer et al. (2026) studied this question.

synapsesocial.com/papers/69a75f05c6e9836116a2a1be https://doi.org/https://doi.org/10.1016/j.rcsop.2026.100711

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper